Chindia Alert: You’ll be Living in their World Very Soon
aims to alert you to the threats and opportunities that China and India present. China and India require serious attention; case of ‘hidden dragon and crouching tiger’.
Without this attention, governments, businesses and, indeed, individuals may find themselves at a great disadvantage sooner rather than later.
The POSTs (front webpages) are mainly 'cuttings' from reliable sources, updated continuously.
The PAGEs (see Tabs, above) attempt to make the information more meaningful by putting some structure to the information we have researched and assembled since 2006.
KOLKATA (Reuters) – Indian and Chinese troops on border patrol duties had a brief skirmish in Sikkim, a northeastern Indian state bordering China, the Indian Defence Ministry said on Sunday, blaming both sides for the incident.
“Aggressive behaviour by the two sides resulted in minor injuries to troops. The two sides disengaged after dialogue and interaction at the local level,” the ministry said in a statement.
The Indian daily Hindustan Times, citing a military source, said four Indian soldiers and seven Chinese troops were injured when some of the soldiers exchanged blows during the confrontation, which it said took place on Saturday and involved some 150 soldiers.
The Defence Ministry said the incident took place in the Nakula area but did not give details of how it started, or what caused the injuries.
China’s Ministry of Defense could not be immediately reached for comment on Sunday.
India and China have often accused each other of intrusions into each other’s territories, but clashes are rare.
There is still deep mistrust between the two countries over their festering border dispute, which triggered a brief war in 1962.
Hundreds of troops from both sides were deployed in 2017 on the Doklam plateau, near the borders of India, Bhutan, and China after India objected to Chinese construction of a road in the Himalayan area, in the most serious standoff in years.
BEIJING/SHANGHAI (Reuters) – A northeastern Chinese city of 10 million people struggling with currently the country’s biggest coronavirus cluster shut dine-in services on Saturday, as the rest of China eases restrictions designed to hamper the spread of the disease.
Harbin, the provincial capital of Heilongjiang and its biggest city, said it temporarily suspended dine-in services for all eateries, reported the official CCTV citing an emergency epidemic prevention notice.
Catering services operating in the city, such as barbecue eateries and those selling skewers, shabu shabu, and stew, shall suspend dine-in meals until further notice and in accordance with changes in the epidemic situation, the notice said.
While mainland China reported only one case on Saturday and crowds returned to some of its most famous tourist attractions for the 5-day May holiday, the northern province of Heilongjiang is hunkering down to prevent further clusters from forming.
Of the 140 local transmissions in mainland China, over half have been reported as from Heilongjiang, according to a Reuters tally.
Heilongjiang province borders Russia and has become the frontline in the fight against a resurgence of the coronavirus epidemic, with many new infections from citizens entering from Russia.
The province has already banned entry to residential zones by non-locals and vehicles registered elsewhere. It had also ordered isolation for those arriving from outside China or key epidemic areas.
On the back of the outbreak, deputy secretary of the Provincial Party Committee Wang Wentao said at a Friday meeting “we deeply blame ourselves”, according to local media.
“We had an inadequate understanding of epidemic prevention and control,” said Wang, adding that the failure to carry out testing in a timely manner contributed to the clusters.
Six animals inoculated with vaccine candidate then exposed to virus did not catch Covid-19 after 28 days
Up to 60 million doses could be produced by Serum Institute of India this year
Microbiologist Elisa Granato gets an injection on Thursday as part of the first human trials in Britain for a potential coronavirus vaccine. Photo: University of Oxford via AP
A leading candidate for a Covid-19 vaccine has shown promising results in animal trials, and is expected to see mass production in India within months.
The Serum Institute of India, the world’s largest maker of vaccines by volume, said on Tuesday that it plans this year to produce up to 60 million doses of a potential vaccine developed by the University of Oxford, which is under clinical trial in Britain.
While the vaccine candidate, called “ChAdOx1 nCoV-19”, is yet to be proven to work against Covid-19, Serum decided to start manufacturing it as it had shown success in animal trials and had progressed to tests on humans, Serum Chief Executive Adar Poonawalla said.
Six rhesus macaque monkeys were inoculated with the vaccine candidate at the National Institutes of Health’s Rocky Mountain Laboratory in Montana last month, according to The New York Times.
Covid-19 vaccine trial starts in Oxford, but remdesivir treatment reportedly flops in China tests
The subjects were exposed afterwards to large quantities of the novel coronavirus, but all six remained healthy after more than 28 days, the newspaper reported, citing researcher Vincent Munster, who conducted the test.
More than 3 million people have been reported to be infected globally and over 210,000 have died from Covid-19, the respiratory disease caused by the coronavirus.
“They are a bunch of very qualified, great scientists [at Oxford] … That’s why we said we will go with this and that’s why we are confident,” Poonawalla told Reuters in a phone interview.
“Being a private limited company, not accountable to public investors or bankers, I can take a little risk and sideline some of the other commercial products and projects that I had planned in my existing facility,” Poonawalla said.
Bill Gates hopes his virus vaccine ‘manufacturing within a year’
27 Apr 2020
As many as 100 potential Covid-19 candidate vaccines are now under development by biotech and research teams around the world, and at least five of these are in preliminary testing in people in what are known as phase one clinical trials.
Poonawalla said he hoped trials of the Oxford vaccine, due to finish in about September, would be successful. Oxford scientists said last week the main focus of initial tests was to ascertain not only whether the vaccine worked but that it induced good immune responses and no unacceptable side effects.
Serum, owned by the Indian billionaire Cyrus Poonawalla, plans to make the vaccine at its two manufacturing plants in the western city of Pune, aiming to produce up to 400 million doses next year if all goes well, Poonawalla said.
“A majority of the vaccine, at least initially, would have to go to our countrymen before it goes abroad,” he said, adding that Serum would leave it to the Indian government to decide which countries would get how much of the vaccine and when.
Rhesus macaque monkeys are often used in animal testing because of their similarity to humans. Photo: AFP
Serum envisages a price of 1,000 rupees (US$14.70) per vaccine, but governments would give it to people without charge, he said.
He said Prime Minister Narendra Modi’s office was “very closely” involved in the vaccine production and the company is hoping the government will help foot the cost of making it.
Over roughly the next five months, Serum will spend some 300 million to 400 million rupees (US$4.4 million to US$5.9 million) on making around 3-5 million doses per month, he said. “[The government] are very happy to share some risk and fund something with us, but we haven’t really pencilled anything down yet,” Poonawalla said.
Coronavirus: clinical trial begins on third vaccine candidate in China
22 Apr 2020
Serum has also partnered with the US biotech firm Codagenix and Austria’s Themis on two other Covid-19 vaccine candidates and plans to announce a fourth alliance in a couple of weeks, he said.
Serum’s board last week also agreed to invest roughly 6 billion rupees (US$8.8 billion) on making a new manufacturing unit to solely produce coronavirus vaccines, Poonawalla said.
SEOUL (Reuters) – South Korean and Chinese officials on Tuesday cast doubt on reports North Korean leader Kim Jong Un was ill after media outlets said he had undergone a cardiovascular procedure and was in “grave danger”.
Daily NK, a Seoul-based speciality website, reported late on Monday, citing one unnamed source in North Korea, that Kim was recovering after undergoing the procedure on April 12. The North Korean leader is believed to be about 36.
CNN cited a U.S. official with direct knowledge of the matter as saying Washington was “monitoring intelligence” that Kim was in grave danger after surgery. Bloomberg quoted an unnamed U.S. official as saying the White House was told that Kim took a turn for the worse after the surgery.
However, two South Korean government officials rejected the CNN report without elaborating on whether Kim had undergone surgery. The presidential Blue House said there were no unusual signs coming from the reclusive, nuclear-capable state.
Kim is the unquestioned leader of North Korea and the sole commander of its nuclear arsenal. He has no clear successor and any instability in the country could be a major international risk.
RELATED COVERAGE
Factbox: Questions hang over North Korea succession amid reports on Kim health
The state KCNA news agency gave no indication of the whereabouts of Kim in routine dispatches on Tuesday, but said he had sent birthday gifts to prominent citizens.
An official at the Chinese Communist Party’s International Liaison Department, which deals with North Korea, told Reuters the source did not believe Kim was critically ill. China is North Korea’s only major ally.
Chinese foreign ministry spokesman Geng Shuang said Beijing was aware of reports about the health of Kim, but said it does not know their source, without commenting on whether it has any information about the situation.
South Korean shares exposed to North Korea tumbled and the Korean won fell on the reports. The won traded down more than 1% against the dollar even as South Korean government sources said Kim was not gravely ill.
U.S. stock futures were trading 0.5% lower, but it was not clear how much of that weakness was owing to the collapse in U.S. oil prices and consequent concerns over global demand.
Daily NK said Kim had been admitted to hospital on April 12, just hours before the cardiovascular procedure, as his health had deteriorated since August due to heavy smoking, obesity and overwork.
It said he was now receiving treatment at a villa in the Mount Myohyang resort north of the capital Pyongyang.
“My understanding is that he had been struggling (with cardiovascular problems) since last August but it worsened after repeated visits to Mount Paektu,” a source was quoted as saying, referring to the country’s sacred mountain.
Accompanied by senior North Korean figures, Kim took two well-publicised rides on a stallion on the snowy slopes of the mountain in October and December.
KIM’S HEALTH KEY TO STABILITY
An authoritative U.S. source familiar with internal U.S. government reporting on North Korea questioned the CNN report that Kim was in “grave danger”.
“Any credible direct reporting having to do with Kim would be highly compartmented intelligence and unlikely to leak to the media,” a Korea specialist working for the U.S. government said on condition of anonymity.
Japan’s top government spokesman, Yoshihide Suga, declined to comment on the reports of Kim’s health.
“We are regularly gathering and analysing information about North Korea with great concern,” he said. “We will keep gathering and analysing information regarding North Korea by collaborating with other countries such as the U.S.”
Kim’s potential health issues could fuel uncertainty over the future of the reclusive state’s dynastic rule and stalled denuclearisation talks with the United States, issues in which Kim wields absolute authority.
With no details known about his young children, analysts say his sister and loyalists could form a regency until a successor is old enough to take over.
Speculation about Kim’s health first arose following his absence from the anniversary of the birthday of its founding father and Kim’s grandfather, Kim Il Sung, on April 15.
On April 12, North Korean state media reported that Kim Jong Un had visited an airbase and observed drills by fighter jets and attack aircraft.
Two days later North Korea launched multiple short-range anti-ship cruise missiles into the sea and Sukhoi jets fired air-to-surface missiles as part of military exercises.
The missile launches were part of the celebrations for Kim’s grandfather, Seoul officials said, but there was no North Korea state media report on his attendance or the tests.
Reporting from inside North Korea is notoriously difficult, especially on matters concerning the country’s leadership, given tight controls on information. There have been false and conflicting reports in the past on matters related to its leaders.
Kim is a third-generation hereditary leader who rules North Korea with an iron-fist, taking over the titles of head of state and commander in chief of the military since late 2011.
In recent years Kim has launched a diplomatic offensive to promote both himself as a world leader and his hermit kingdom, holding three meetings with U.S. President Donald Trump, four with South Korean President Moon Jae-in and five with China’s President Xi Jinping.
He was the first North Korean leader to cross the border into South Korea to meet Moon in 2018. Both Koreas are technically still at war, as the Korean War of 1950-53 ended in an armistice, not a peace treaty.
Kim has sought to have international sanctions against his country eased, but has refused to dismantle his nuclear weapons programme, a steadfast demand by the United States.
MOSCOW (Reuters) – Russia will begin delivering S-400 surface-to-air missile systems to India by the end of 2021, agency RIA Novosti on Wednesday quoted a Russian official as saying.
India signed a $5 billion deal for S-400 missiles in 2018, drawing warnings from the United States that such an acquisition would trigger sanctions as part of a wider programme against Russia.
“The contract is being implemented on schedule. The first shipment is due by the end of 2021,” Deputy Director of the Federal Service for Military-Technical Cooperation (FSMTC), Vladimir Drozhzhov, said at Defence Expo 2020 in Lucknow, India, according to RIA.
In November, the same agency cited the general director of Russian state arms exporter Rosoboronexport, Alexander Mikheev, as saying deliveries would start in September 2021.
CHINDIA ALERT: You'll be living in their world, very soon 
Indian, Chinese border troops in brief skirmish on northeast Indian border, India says
KOLKATA (Reuters) – Indian and Chinese troops on border patrol duties had a brief skirmish in Sikkim, a northeastern Indian state bordering China, the Indian Defence Ministry said on Sunday, blaming both sides for the incident.
“Aggressive behaviour by the two sides resulted in minor injuries to troops. The two sides disengaged after dialogue and interaction at the local level,” the ministry said in a statement.
The Indian daily Hindustan Times, citing a military source, said four Indian soldiers and seven Chinese troops were injured when some of the soldiers exchanged blows during the confrontation, which it said took place on Saturday and involved some 150 soldiers.
The Defence Ministry said the incident took place in the Nakula area but did not give details of how it started, or what caused the injuries.
China’s Ministry of Defense could not be immediately reached for comment on Sunday.
India and China have often accused each other of intrusions into each other’s territories, but clashes are rare.
There is still deep mistrust between the two countries over their festering border dispute, which triggered a brief war in 1962.
Hundreds of troops from both sides were deployed in 2017 on the Doklam plateau, near the borders of India, Bhutan, and China after India objected to Chinese construction of a road in the Himalayan area, in the most serious standoff in years.
Source: Reuters
Posted in 1962, 2017, accused, aggressive, behaviour, Bhutan, blaming, border, bordering, both, brief, China, China’s, Chinese, citing, clashes, comment, confrontations, Construction, countries, daily, deep, defence ministry, deployed, details, dialogue, disengaged, dispute, duties, festering, four, Himalayan, Hindustan Times, hundreds, immediately, incident, India, Indian, Indian soldiers, injured, injuries, interaction, intrusions, involved, Kolkata, level, local, Military, ministry, Ministry of Defense, minor, mistrust, Nakula, Northeast, Northeastern, patrol, rare, reached, resulted, roads, Saturday, serious, seven, sides, Sikkim, skirmish, source, standoff, state, statement, Sunday, territories, triggered, troops, two, Uncategorized, war, years | Leave a Comment »